Fanhdi (Human Coagulation Factor Viii)

Fanhdi is a human coagulation factor VIII used to manage bleeding episodes in hemophilia A. This intravenous medication helps replace missing clotting factors to control bleeding.

Fanhdi is primarily used to treat and prevent bleeding episodes in individuals with hemophilia A, a condition where the body lacks sufficient factor VIII. It is designed to replace the missing clotting factor, helping to control and prevent bleeding. This medication is often used in situations where bleeding needs to be managed quickly and effectively.

Common effects of Fanhdi may include mild reactions at the injection site, such as redness or swelling. Some users might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

Fanhdi should be handled with care and stored as directed to maintain its effectiveness. It is important to use this medication under the supervision of a healthcare professional. Individuals with known allergies to factor VIII or any of its components should avoid using Fanhdi.

Fanhdi may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting or stopping any medication.